---
title: "PDSB.US (PDSB.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PDSB.US/news.md"
symbol: "PDSB.US"
name: "PDSB.US"
parent: "https://longbridge.com/en/quote/PDSB.US.md"
datetime: "2026-05-21T02:04:00.922Z"
locales:
  - [en](https://longbridge.com/en/quote/PDSB.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PDSB.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PDSB.US/news.md)
---

# PDSB.US (PDSB.US) — Related News

### [ACCESS Newswire Q1 2026 Earnings Call: Complete Transcript](https://longbridge.com/en/news/286111295.md)
*2026-05-12T13:33:16.000Z*
> ACCESS Newswire (AMEX:ACCS) reported Q1 2026 revenues of $5.3 million, a decline from previous quarters. However, custom

### [PDS Biotechnology Q1 2026 earnings preview](https://longbridge.com/en/news/286130832.md)
*2026-05-12T16:11:18.000Z*
> PDS Biotechnology (PDSB) will announce its Q1 earnings on May 13th, before market open. The consensus EPS estimate is -$

### [PDS Biotechnology Refinances Debt with New Note, Warrant](https://longbridge.com/en/news/284924182.md)
*2026-05-01T17:09:49.000Z*
> PDS Biotechnology has announced a refinancing of its debt through a $6 million promissory note and a warrant for common 

### [PDS Biotechnology updates corporate presentation highlighting Phase 3 VERSATILE-003, 39.3m mOS and upcoming catalysts](https://longbridge.com/en/news/284050202.md)
*2026-04-24T20:13:01.000Z*
> PDS Biotechnology has updated its corporate presentation, focusing on the progress of Phase 3 VERSATILE-003, which repor

### [Pre-market hot trades in US stocks: PDS Biotechnology up 7.53% in pre-market; Wing Yip Food China down 4.41% in pre-market](https://longbridge.com/en/news/283970686.md)
*2026-04-24T09:28:02.000Z*
> PDS Biotechnology pre-market up 7.53%; Wing Yip Food China pre-market down 4.41%; Freecast pre-market up 63.10%; iTonic 

### [Pre-market hot trades in US stocks: Eightco up 9.68% in pre-market; PDS Biotechnology down 9.38% in pre-market](https://longbridge.com/en/news/283112211.md)
*2026-04-17T08:27:55.000Z*
> Eightco pre-market up 9.68%; PDS Biotechnology pre-market down 9.38%; Psyence Biomedical pre-market up 94.38%; YXT.COM p

### [PDS Biotech Reports Strong Interim Data With PDS01ADC In Colorectal Cancer, Stock Up](https://longbridge.com/en/news/282925796.md)
*2026-04-16T02:20:16.000Z*
> PDS Biotechnology Corporation (PDSB) reported positive interim Phase 2 results for its immunocytokine PDS01ADC in metast